Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) ROCE % : 12.37% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Jiuzhou Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zhejiang Jiuzhou Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 12.37%.

Zhejiang Jiuzhou Pharmaceutical Co ROCE % Historical Data

The historical data trend for Zhejiang Jiuzhou Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jiuzhou Pharmaceutical Co ROCE % Chart

Zhejiang Jiuzhou Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

9.39

14.41

18.49

21.14

16.14

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															19.87	17.46	17.09	4.21	12.37

Zhejiang Jiuzhou Pharmaceutical Co ROCE % Calculation

Zhejiang Jiuzhou Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	1202.376	/	( ( (7913.707 - 2213.993)	+	(10851.987 - 1656.62) )	/ 2 )
	=	1202.376	/	( (5699.714	+	9195.367)	/ 2 )
	=	1202.376	/	7447.5405
	=	16.14 %

Zhejiang Jiuzhou Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	1152.448	/	( ( (10851.987 - 1656.62)	+	(12249.806 - 2816.696) )	/ 2 )
	=	1152.448	/	( ( 9195.367	+	9433.11 )	/ 2 )
	=	1152.448	/	9314.2385
	=	12.37 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zhejiang Jiuzhou Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Zhejiang Jiuzhou Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

99 Waisha Road, Jiaojiang District, Taizhou, Zhejiang, CHN, 318000

Website

http://www.jiuzhoupharma.com

Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.

Executives

Sha Yu Jie	Directors, senior managers
Mei Yi Jiang	Director
Li Yuan Qiang	senior management
Yang Nong Gang	senior management
	Directors, senior managers
Huang Min Xia	senior management
Wang Bin	Directors, senior managers
Dai Yun You	senior management
Jiang Zu Lin	Directors, senior managers
Guo Zhen Rong	senior management
Chen Zhi Hong	Directors, senior managers
Xu Jia Jun	Supervisors
Hua Li Rong	Director
Lin Hui Lu	senior management
Zhu Guo Liang	Supervisors

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Headlines

No Headlines